Company BELLUS Health

Equities

BLU

CA07987C2040

Biotechnology & Medical Research

Business Summary

Managers

Members of the board

Share class

Company contact information

Sector

Sector Bio Therapeutic Drugs

Delayed Toronto S.E. Other stock markets 01:30:00 30/06/2023 am IST			5-day change	1st Jan Change
19.48 ^CAD	-0.10%		-.--%	-.--%

2023	BELLUS Health Inc.(TSX:BLU) dropped from S&P/TSX Capped Composite Index	CI
2023	BELLUS Health Inc.(TSX:BLU) dropped from S&P/TSX Completion Index	CI

BELLUS Health Inc. is a Canada-based clinical-stage biopharmaceutical company. The Company is focused on the lives of patients suffering from persistent cough, starting with the development of camlipixant (BLU-5937) for the treatment of refractory chronic cough (RCC). Camlipixant is a highly selective antagonist of the P2X3 receptor, a clinically validated target to treat cough hypersensitivity. It is being evaluated in the CALM phase III clinical development programmed. It is developing camlipixant for the treatment of adults with RCC. Camlipixant has the potential to address the significant unmet need for an efficacious, safe and well tolerated treatment for refractory chronic cough.

Number of employees: 74

Managers	Title	Age	Since
Roberto Bellini CEO	Chief Executive Officer	44	05/09/05
Jeremy Martin PSD	President	-	-
Francesco Bellini CHM	Chairman	77	01/02/01
Ramzi Benamar DFI	Director of Finance/CFO	51	07/20/07
Reena Colacot CMP	Compliance Officer	-	01/21/01
Chuck Stanley CTO	Chief Tech/Sci/R&D Officer	-	01/22/01
Denis Garceau CTO	Chief Tech/Sci/R&D Officer	67	01/97/01
Joan Shaw CTO	Chief Tech/Sci/R&D Officer	-	01/20/01
Catherine Bonuccelli CTO	Chief Tech/Sci/R&D Officer	-	26/19/26
Andreas Orfanos COO	Chief Operating Officer	-	01/04/01

Members of the board	Title	Age	Since
Francesco Bellini CHM	Chairman	77	01/02/01
Franklin Berger BRD	Director/Board Member	74	01/10/01
Pierre Larochelle BRD	Director/Board Member	52	01/09/01
Joseph Rus BRD	Director/Board Member	78	01/09/01
Roberto Bellini CEO	Chief Executive Officer	44	05/09/05
Clarissa Desjardins BRD	Director/Board Member	57	27/17/27
Youssef Bennani BRD	Director/Board Member	63	01/17/01
Jeremy Martin PSD	President	-	-

	Vote	Quantity	Free-Float	Company-owned shares	Total Float
Stock A	1	126,812,170	103,381,552 ( 81.52 %)	0	81.52 %

BELLUS Health, Inc.

275, boulevard Armand-Frappier

H7V 4A7, Laval

+450 680 4500

http://www.bellushealth.com

Healthcare

Pharmaceuticals & Medical Research

Biotechnology & Medical Research

Biotechnology & Medical Research

Bio Therapeutic Drugs

	1st Jan change	Capi.
BELLUS HEALTH	-.--%	1.87B
VERTEX PHARMACEUTICALS INCORPORATED	-2.62%	103B
REGENERON PHARMACEUTICALS, INC.	+1.53%	95.28B
ARGENX SE	+1.46%	22.15B
BIONTECH SE	-15.87%	21.02B
GENMAB A/S	-8.58%	18.15B
WUXI APPTEC CO., LTD.	-38.74%	16.73B
BEIGENE, LTD.	-13.02%	16.05B
NEUROCRINE BIOSCIENCES, INC.	+5.16%	13.68B
SAREPTA THERAPEUTICS, INC.	+33.86%	12.17B

Bio Therapeutic Drugs